4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000013
Chief Executive Officer sold 8,767 shares at an average $23.83 ($208,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salzmann Peter Chief Executive Officer | 2025-01-15 | Sale | −8,352 | $23.81 | $198,861 | 964,640 | D |
| Salzmann Peter Chief Executive Officer | 2025-01-15 | Sale | −415 | $24.19 | $10,039 | 964,225 | D |
| Open-market sales · 8,767 sh · avg $23.83 · $208,900 | |||||||
Loading xslF345X05/wk-form4_1737147867.xml…